About
Pliant Therapeutics Inc (NASDAQ:PLRX) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 18 2026
Pliant Therapeutics Announces Presentation of Updated Data from the Phase 1 Trial of PLN-101095 in Patients with ICI-Refractory Solid Tumors at the 2026 AACR Annual Meeting
Mar 18 2026
Pliant Therapeutics Announces Upcoming Presentation of Phase 1 Clinical Trial of PLN-101095 in Patients with Solid Tumors at the 2026 AACR Annual Meeting
Mar 11 2026
Pliant Therapeutics Provides Corporate Update and Reports Fourth Quarter 2025 Financial Results
Feb 23 2026
Pliant Therapeutics to Participate in the Oppenheimer Healthcare Life Science Conference
Jan 9 2026
Enhanced Genomics Appoints Dr Katerina Leftheris to Its Board of Directors
Recent Videos

Pliant Therapeutics, Inc. (PLRX) #fibrosis #liver_fibrosis #nonalcoholic_steatohepatitis
Mar 12, 2026

Biotech-Aktie Pliant Therapeutics unter Netcash nun kaufen?! Lies den Top 3 Net-Net-Aktien-Report!
Jan 25, 2026

Minnie Kuo's COO Role: My Insight from Pliant Therapeutics Filing
Dec 22, 2025

Pliant Therapeutics: My Take on the CMO's Departure
Dec 11, 2025
Financials
Revenue
$0
Market Cap
$83.58 M
EPS
-2.43
Translate